In obesity, adipocyte levels of PU.1 are significantly increased and thus further understanding the aberrant transcriptional changes mediated by PU.1 may provide important therapeutic targets in the treatment of obesity-induced insulin resistance. Here, SPI1 is linked to obesity due to melanocortin 4 receptor deficiency.